The Online Investor
Daily M&A
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com



Slideshow Mergers & Acquisitions

By The Online Investor Staff, updated Tue., Mar. 19, 1:45 AM

Slide #39. Branded Legacy Sycamore BioPharma, Inc

Acquirer: Branded Legacy (BLEG)
Acquiree: Sycamore BioPharma, Inc
Details: Branded Legacy (OTC.PK: BLEG), Inc., a trailblazing BioTech holdings company, proudly announces the strategic acquisition of Sycamore BioPharma, Inc, a distinguished developer of plant-based pharmaceuticals. This strategic milestone not only fortifies Branded Legacy's standing as a prominent player in the biotech sector but also secures assets exceeding $2 million, along with key personnel crucial for advancing clinical trials following this successful union.

  Branded Legacy: BLEG
  Sycamore BioPharma, Inc: PRIVATE
 

Open the GNS Page at The Online Investor (in a new window) »

March 19, 2024    1:45 AM Eastern
Quotes delayed 20 minutes

Email EnvelopeFree GNS Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Mergers & Acquisitions | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.